Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma

doi:10.3748/wjg.v10.i15.2195

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 15

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2699)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

290

HTML

2222

Figures (1-6)

187

Sum=2699

Aug 1, 2004 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Aug 1, 2004; 10(15): 2195-2200
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2195

Full Size Figure Download Figure

Figure 2 Hepatoma formation and growth inhibited by gene therapy of endostatin and IL- 12. Each bar represents tumor weight of mice treated with PVP/NaCl, pcDNA3.1/PVP, pSecES/PVP, pmIL-12/PVP or pSecES + pmIL-12/PVP, and mean ± SD for six mice. P < 0.01 by ANOVA analysis.

Citation: Li PY, Lin JS, Feng ZH, He YF, Zhou HJ, Ma X, Cai XK, Tian DA. Combined gene therapy of endostatin and interleukin 12 with polyvinylpyrrolidone induces a potent antitumor effect on hepatoma. World J Gastroenterol 2004; 10(15): 2195-2200
URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2195.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2195